Leucine catabolic enzyme AUH regulates BAT thermogenesis via PPARγ HMGylation and RNA-binding function in male mice.
Summary
This mechanistic study identifies AUH as a dual-function regulator of thermogenesis: via metabolite-driven HMGylation of PPARγ (K386) that boosts UCP1 transcription and via RNA-binding that stabilizes Ucp1 mRNA. AUH overexpression promotes browning and protects male mice from diet-induced obesity, linking leucine catabolism to adipose thermogenesis.
Key Findings
- HMG-CoA mediates PPARγ HMGylation at lysine 386, enhancing UCP1 transcription and thermogenesis.
- AUH binds and stabilizes Ucp1 mRNA, providing a second, RNA-mediated mechanism to increase UCP1.
- AUH overexpression induces browning and protects male mice from high-fat diet–induced obesity; AUH expression in human WAT inversely correlates with adiposity.
Clinical Implications
While preclinical, modulating AUH activity or PPARγ HMGylation could be explored to enhance brown/beige fat function and energy expenditure in obesity and metabolic disease.
Why It Matters
It discovers a previously unrecognized post-translational modification (HMGylation) of PPARγ that directly controls thermogenesis, offering a new mechanistic axis and potential target for obesity therapies.
Limitations
- Predominant use of male mice may limit generalizability to females.
- Translational applicability and safety of targeting AUH/PPARγ HMGylation remain untested in humans.
Future Directions
Validate PPARγ HMGylation in human thermogenic adipocytes, define sex-specific effects, and develop pharmacologic modulators of AUH/HMG-CoA flux to test metabolic efficacy and safety.
Study Information
- Study Type
- Basic/Mechanistic research
- Research Domain
- Pathophysiology
- Evidence Level
- V - Preclinical mechanistic evidence from cellular and animal models
- Study Design
- OTHER